comparemela.com

Latest Breaking News On - Usfda - Page 1 : comparemela.com

Transcripts For BBCNEWS BBC News

after europe s medicines regulator says the jab is safe and effective. meanwhile, the us has announced it will release four million doses of the astrazeneca coronavirus vaccine to its neighbours, canada and mexico. we start with those first top level meetings between the us and china. it s a chance to re set relations between the world s two biggest economies under a biden presidency. but there s no indication so far that things are improving. america s top diplomat antony blinken is meeting his opposite number against the snowy backdrop of alaska. and in their opening remarks, not too many warm words. (sots today we will have an opportunity to discuss key priorities, both domestic and global, priorities, both domestic and global, so that china can better global, so that china can better understand our administration s intentions and approach administration s intentions and approach. we will also discuss our deep approach. we will also discuss our deep concerns with ac

Presidentjoe-biden
China
Administration
Talks
Bbc-news
Words
Sides
Top-stories
Issues
Actions
Stability
Peach

Gland Pharma gets USFDA nod for generic Edaravone injection

The approval by the US Food and Drug Administration (USFDA) is for Edaravone injection of strengths 30 mg/100 ml and 60 mg/100 ml single-dose bags, Gland Pharma said in a regulatory filing.

Mitsubishi-tanabe-pharma-corporation
Drug-administration
Gland-pharma-ltd-on
Gland-pharma
Pharma-ltd
Business
Companies
Usfda

Cipla, Glenmark recall drugs from US market: USFDA

International Business News: NEW DELHI: Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regu.

India
United-states
Indore
Madhya-pradesh
Japan
Australia
American
Glenmark-pharma
Glenmark-pharmaceuticals-inc
Cipla
Drug-administration
Enforcement-report

Morgan Stanley: Maiva Pharma raises Rs 1,000 cr from Morgan Stanley PE and India Life Sciences Fund

Maiva Pharma has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund, including both primary and secondary funding. The funds will be used to set up a new manufacturing facility near Karnataka s Hosur, with capabilities in sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. Maiva s complex injectables development and manufacturing capability, strong compliance and regulatory standards, and transparency differentiate the company from competitors.

Bengaluru
Karnataka
India
Karnataka-hosur
Sumit-gupta
Bhaskar-krishna
Nirav-mehta
India-life-sciences-fund
Maiva-pharma
Morgan-stanley-private-equity-asia
India-life-sciences
Managing-director

Granules gets USFDA nod for generic gout medication

Granules Pharmaceuticals, Inc, a wholly-owned foreign subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) for Colchicine Capsules (0.6 mg), it said in a regulatory filing.

Granules-pharmaceuticals-inc
Us-food-drug-administration
Hikma-international-pharmaceuticals
Granules-india
Drug-administration
Colchicine-capsules
Business
Companies
Granules
Usfda

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.